Sreelakshmi Ravula Institution Verified
Sourced from institutional research profiles (UAMS TRI or ARA).
Associate Professor
University of Arkansas for Medical Sciences
faculty
Internal Medicine, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Sreelakshmi Ravula, Associate Professor in Internal Medicine at the University of Arkansas for Medical Sciences, investigates critical care and kidney disease. Her recent publications examine predictors of adverse outcomes in patients with acute kidney injury following cardiac surgery, as well as the role of acidosis in chronic kidney and liver disease. She has also published on complex clinical cases including unresolving hypokalemia and dialysis-associated reactions. Ravula's work also explores novel approaches to reversing anuric acute kidney injury through intra-abdominal pressure reduction. Her research network includes collaborators such as Joseph H. Holthoff and Omar Dodin from the University of Arkansas for Medical Sciences, with whom she has co-authored multiple publications. Ravula's scholarly output is reflected in her h-index of 3 and a total of 735 citations across 8 publications.
Metrics
- h-index: 3
- Publications: 8
- Citations: 735
Selected Publications
- Perfusion Under Pressure: Reversing Anuric AKI with Targeted Intra-Abdominal Pressure (IAP) Reduction (2025) DOI
- A Case of Unresolving Hypokalemia (2024) DOI
- A Curious Case of Dialysis-Associated Reaction (2024) DOI
- Urinary Complement C3 and Vitamin D-Binding Protein Predict Adverse Outcomes in Patients with Acute Kidney Injury after Cardiac Surgery (2024) DOI
- No Good Deed: Acidosis in Chronic Kidney and Liver Disease (2023) DOI
Grants & Funding
- A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PARALLEL-GROUP, ACTIVE CONTROL STUDY OF THE EFFICACY AND SAFETY OF SPARSENTAN FOR THE TREATMENT OF IMMUNOGLOBULIN A NEPHROPATHY (IRB 262333) Travere Therapeutics Principal Investigator
- No FP attached Retrophin, Inc. - Pass Through: IQVIA, Inc. Principal Investigator
- Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (IRB 274955) NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Benaroya Research Institute at Virginia Mason Principal Investigator
- Efficacy of Belimumab and Rituximab Compared to Rituximab Alone for the Treatment of Primary Membranous Nephropathy (IRB 274955) NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Benaroya Research Institute at Virginia Mason Principal Investigator
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics